Found: 6
Select item for more details and to access through your institution.
Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in 6211 chronic HCV genotype IV infected patients.
- Published in:
- Liver International, 2017, v. 37, n. 4, p. 534, doi. 10.1111/liv.13266
- By:
- Publication type:
- Article
Inflammasome Genes' Polymorphisms in Egyptian Chronic Hepatitis C Patients: Influence on Vulnerability to Infection and Response to Treatment.
- Published in:
- Mediators of Inflammation, 2019, p. 1, doi. 10.1155/2019/3273645
- By:
- Publication type:
- Article
Impact of IL12B Gene rs 3212227 Polymorphism on Fibrosis, Liver Inflammation, and Response to Treatment in Genotype 4 Egyptian Hepatitis C Patients.
- Published in:
- Disease Markers, 2013, v. 35, n. 5, p. 431, doi. 10.1155/2013/627589
- By:
- Publication type:
- Article
Hepatic Expression of the Proliferative Marker Ki-67 and cell cycle p53 Protein in chronic hepatitis C (A histopathological and immunohistochemical study).
- Published in:
- Egyptian Journal of Hospital Medicine, 2011, v. 42, p. 1
- By:
- Publication type:
- Article
The impact of polymorphism in PNPLA3 and TM6SF2 genes on the susceptibility and survival of hepatitis C-related hepatocellular carcinoma.
- Published in:
- Egyptian Liver Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1186/s43066-022-00212-0
- By:
- Publication type:
- Article
Association of liver inflammation with alpha-fetoprotein and treatment response in hepatitis C virus genotype 4 patients.
- Published in:
- Journal of Experimental & Integrative Medicine, 2014, v. 4, n. 1, p. 23, doi. 10.5455/jeim.071013.or.093
- By:
- Publication type:
- Article